Drug Repurposing in Cancer Research

Häftad, Engelska, 2027

2 489 kr

Kommande

Drug Repurposing in Cancer Research investigates the innovative use of drug repurposing in oncology, focusing on emerging and re-emerging cancer types. The book provides a comprehensive yet concise overview of current trends, making it an essential resource for academics and professionals in the field. Structured into 21 chapters, the book presents foundational facts alongside practical and clinically relevant data. It covers topics ranging from market dynamics to AI-driven transformations in cancer treatment, highlighting the rapid advancements in oncology. This compilation ensures that readers are equipped with the latest information necessary for effective research and development. For pharmaceutical researchers, biomedical scientists, and clinicians, "Drug Repurposing in Cancer Research" offers valuable insights into the growing demand for innovative cancer treatments. It serves as a timely resource for understanding the potential of repurposed drugs, supporting efforts in cancer prevention and treatment strategies.

Provides a thorough yet concise examination of current trends in drug repurposing and theranostics within oncology
Offers foundational facts alongside actionable insights, supporting effective research and clinical applications
Highlights the rapid advancements and market dynamics in cancer treatment, ensuring readers stay informed about the latest developments

Produktinformation

Utgivningsdatum2027-02-01
Mått191 x 235 x undefined mm
Vikt450 g
FormatHäftad
SpråkEngelska
Antal sidor330
FörlagElsevier Science
ISBN9780443451850

Tillhör följande kategorier

Farmakologi inom Medicin

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)Yashwant Pathak is a Professor at Taneja College of Pharmacy at the University of South Florida, FL, United States. His area of research is nanotechnology, drug delivery systems, and nutraceuticals. He is also an Ad junct Professor at the Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia.

1. Drug Repurposing in Liver Cancer2. Drug Repurposing in Pancreatic Cancer3. Drug Repurposing in Heart/Cardiac Cancer4. Drug Repurposing in Bone Cancer5. Drug Repurposing in Spleen Cancer6. Drug Repurposing in ENT Cancer7. Drug Repurposing in Brain/CNS Cancer8. Drug Repurposing in Skin Cancer9. Drug Repurposing in Lung Cancer10. Drug Repurposing in Thorax Cancer11. Drug Repurposing in Thyroid Cancer12. Drug Repurposing in Kidney-Adrenal Cancer13. Drug Repurposing in Urinary Tract Cancer14. Drug Repurposing in Breast Cancer15. Drug Repurposing in Colorectal Cancer16. Drug Repurposing in Blood Cancer17. Drug Repurposing in Prostate Cancer18. Drug Repurposing in Ovarian Cancer19. Drug Repurposing in Stomach and Intestinal Cancer20. Drug Repurposing in Pleura and Peritoneum Cancer21. Drug Repurposing in Oral Cancer